P. Revilla-Martí

Impact of an endurance training program on exercise-induced cardiac biomarker release.

K. George, C. Mayolas-Pi, J. Reverter-Masià, 2015, American journal of physiology. Heart and circulatory physiology.

Efficacy and safety of abciximab versus tirofiban in addition to ticagrelor in STEMI patients undergoing primary percutaneous intervention

P. Revilla-Martí, J. R. Ruiz Arroyo, A. Lukic, 2021, Platelets.

High-degree atrioventricular block. An unusual presentation of Takotsubo cardiomyopathy: a case report

P. Revilla-Martí, J. A. Linares-Vicente, J. F. Cueva-Recalde, 2021, The Egyptian Heart Journal.

No Differences in Gastrointestinal Bleeding Risk among Clopidogrel-, Ticagrelor-, or Prasugrel-Based Dual Antiplatelet Therapy

Á. Lanas, P. Revilla-Martí, C. Sostres, 2020, Journal of clinical medicine.

Ventricular tachycardia in a patient with cardiac haemochromatosis and normal left-ventricular ejection fraction

P. Revilla-Martí, J. A. Linares-Vicente, J. Ruiz-Arroyo, 2019, Seminars in Cardiovascular Medicine.

Alpha-protein kinase 3 (ALPK3) truncating variants are a cause of autosomal dominant hypertrophic cardiomyopathy

P. Elliott, L. Monserrat, P. Syrris, 2021, European heart journal.

Acute Myopericarditis Associated with Tickborne Rickettsia sibirica mongolitimonae

P. Revilla-Martí, J. Oteo, J. A. Linares-Vicente, 2017, Emerging infectious diseases.

Prevalence, clinical characteristics and associated factors of cardiac cephalalgia: A prospective study

P. Revilla-Martí, Jes Olesen, S. Santos-Lasaosa, 2023, Cephalalgia : an international journal of headache.

Empiema pleural por Streptococcus constellatus

P. Revilla-Martí, C. López-Núñez, 2011 .

Prevalence of neurological complications in infective endocarditis.

P. Revilla-Martí, S. Santos-Lasaosa, J. Rodríguez-Montolio, 2023, Neurologia.